Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Harm reduction and equity of access to care for French prisoners: a review | Harm Reduction Journal BioMed Central Open Access Harm reduction and equity of access to care for French prisoners a review Laurent MicheP1 2 3 M Patrizia Carrieri 44 5 and Alex Wodak6 Address 1Health and Medical Research National Institute Research Unit 669 Paris France 2University of Paris-Sud and University Paris Descartes umr-s0669 Paris France 3Emile Roux Hospital Limeil-Brévannes France 4Inserm umr912 Economic Social Sciences Health Systems Societies Marseille France Southeastern Health Regional Observatory ORS-PACA Marseille France and 6St. Vincent s Hospital Sydney Australia Email Laurent Michel - M Patrizia Carrieri - pmcarrieri@ Alex Wodak - awodak@ Corresponding author fEqual contributors Published 21 May 2008 Received 30 December 2007 Harm Reduction Journal 2008 5 17 doi 1477-7517-5-17 Accepted 21 May 2008 This article is available from http content 5 l l7 2008 Michel et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Despite France being regarded as a model of efficient harm reduction policy and equity of access to care in the general community the health of French inmates is a critical issue as harm reduction measures are either inaccessible or only partially implemented in French prisons. Method Using specific inclusion and exclusion criteria information was collected and analyzed about HIV HBV and HCV prevalence risk practices mortality access to harm reduction measures and care for French prison inmates. Results Data about the occurrence of bloodborne diseases drug use and access to care in prisons remain limited and need urgent updating. Needle exchange programs are not yet available in .
